Connection

Miguel Abboud to Child

This is a "connection" page, showing publications Miguel Abboud has written about Child.
Connection Strength

2.549
  1. Voxelotor for the treatment of sickle cell disease in pediatric patients. Expert Rev Hematol. 2022 06; 15(6):485-492.
    View in: PubMed
    Score: 0.094
  2. Emergence of gram-negative organisms as the cause of infections in patients with sickle cell disease. Pediatr Blood Cancer. 2021 01; 68(1):e28784.
    View in: PubMed
    Score: 0.084
  3. Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Cochrane Database Syst Rev. 2020 04 06; 4:CD012389.
    View in: PubMed
    Score: 0.081
  4. Standard management of sickle cell disease complications. Hematol Oncol Stem Cell Ther. 2020 Jun; 13(2):85-90.
    View in: PubMed
    Score: 0.081
  5. Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon. J Glob Oncol. 2019 04; 5:1-8.
    View in: PubMed
    Score: 0.075
  6. Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia. Curr Res Transl Med. 2017 09; 65(3):115-119.
    View in: PubMed
    Score: 0.068
  7. Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Cochrane Database Syst Rev. 2017 05 13; 5:CD012389.
    View in: PubMed
    Score: 0.066
  8. The Daily Experiences of Adolescents in Lebanon With Sickle Cell Disease. J Pediatr Health Care. 2015 Sep-Oct; 29(5):424-34.
    View in: PubMed
    Score: 0.057
  9. Acute lymphoblastic leukemia in low and middle-income countries: disease characteristics and treatment results. Curr Opin Oncol. 2014 Nov; 26(6):650-5.
    View in: PubMed
    Score: 0.056
  10. Educational intervention to improve the health outcomes of children with sickle cell disease. J Pediatr Health Care. 2015 Jan-Feb; 29(1):54-60.
    View in: PubMed
    Score: 0.055
  11. Quality of palliative care in children with cancer in Lebanon. J Med Liban. 2013 Oct-Dec; 61(4):228-36.
    View in: PubMed
    Score: 0.052
  12. Intracranial blood flow velocities in patients with sickle cell disease and ?-thalassemia intermedia. Am J Hematol. 2013 Sep; 88(9):825.
    View in: PubMed
    Score: 0.051
  13. Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon. Am J Hematol. 2012 Jul; 87(7):678-83.
    View in: PubMed
    Score: 0.047
  14. Cerebral infarction in children with sickle cell disease: a concise overview. Hemoglobin. 2011; 35(5-6):618-24.
    View in: PubMed
    Score: 0.045
  15. Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II. Blood. 2011 Jul 28; 118(4):894-8.
    View in: PubMed
    Score: 0.044
  16. Stem-cell transplantation in children and adults with sickle cell disease: an update. Expert Rev Hematol. 2011 Jun; 4(3):343-51.
    View in: PubMed
    Score: 0.044
  17. Predictors of bone loss in childhood hematologic malignancies: a prospective study. Osteoporos Int. 2012 Feb; 23(2):665-74.
    View in: PubMed
    Score: 0.043
  18. Bereaved parental evaluation of the quality of a palliative care program in Lebanon. Pediatr Blood Cancer. 2011 Aug; 57(2):310-6.
    View in: PubMed
    Score: 0.043
  19. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease. Pediatr Blood Cancer. 2010 Dec 15; 55(7):1338-42.
    View in: PubMed
    Score: 0.042
  20. L-asparaginase-induced pancreatitis in children with acute lymphoblastic leukemia: is allopurinol protective? Pediatr Hematol Oncol. 2010 Sep; 27(6):496-501.
    View in: PubMed
    Score: 0.042
  21. Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering. Pediatr Blood Cancer. 2010 Mar; 54(3):398-402.
    View in: PubMed
    Score: 0.040
  22. Limb salvage surgery for children and adolescents with malignant bone tumors in a developing country. Pediatr Blood Cancer. 2008 Dec; 51(6):787-91.
    View in: PubMed
    Score: 0.037
  23. Iron deficiency in young Lebanese children: association with elevated blood lead levels. J Pediatr Hematol Oncol. 2008 May; 30(5):382-6.
    View in: PubMed
    Score: 0.035
  24. Spontaneous splenic rupture in a patient with factor XIII deficiency and a novel mutation. Pediatr Blood Cancer. 2008 Jan; 50(1):113-4.
    View in: PubMed
    Score: 0.035
  25. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels. Pediatr Blood Cancer. 2008 Jan; 50(1):62-5.
    View in: PubMed
    Score: 0.035
  26. Primary malignant peripheral nerve sheath tumor of the lung in a young child without neurofibromatosis type 1. Pediatr Blood Cancer. 2006 Oct 15; 47(5):636-8.
    View in: PubMed
    Score: 0.032
  27. Prevention and management of strokes in patients with sickle cell disease. Curr Hematol Rep. 2006 Mar; 5(1):15-22.
    View in: PubMed
    Score: 0.030
  28. Radiographic predictors of neurocognitive functioning in pediatric Sickle Cell disease. J Child Neurol. 2006 Jan; 21(1):37-44.
    View in: PubMed
    Score: 0.030
  29. Clinical presentation and treatment outcome of children with Burkitt lymphoma in Lebanon: a single institution's experience. J Pediatr Hematol Oncol. 2004 Nov; 26(11):749-53.
    View in: PubMed
    Score: 0.028
  30. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood. 2004 Apr 01; 103(7):2822-6.
    View in: PubMed
    Score: 0.026
  31. Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study. Blood. 2022 09 29; 140(13):1470-1481.
    View in: PubMed
    Score: 0.024
  32. Causes of New-Onset Seizures and Their Treatment in Children With Non-CNS Malignancies: A Retrospective Study in a Tertiary Care Center. Pediatr Neurol. 2022 12; 137:17-21.
    View in: PubMed
    Score: 0.024
  33. Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11?years. Pediatr Blood Cancer. 2022 08; 69(8):e29716.
    View in: PubMed
    Score: 0.023
  34. Vincristine-induced neurotoxicity in pediatric patients with rhabdomyosarcoma: A retrospective analysis of clinical features and outcome. Pediatr Hematol Oncol. 2022 Oct; 39(7):644-649.
    View in: PubMed
    Score: 0.023
  35. Long-term follow-up of children treated with the Repiphysis expandable prosthesis for lower extremity bone sarcoma. J Pediatr Orthop B. 2022 Mar 01; 31(2):e258-e263.
    View in: PubMed
    Score: 0.023
  36. Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider. Pediatr Blood Cancer. 2021 11; 68(11):e29210.
    View in: PubMed
    Score: 0.022
  37. Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Haematol. 2021 May; 8(5):e334-e343.
    View in: PubMed
    Score: 0.022
  38. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA. 2021 04 20; 325(15):1513-1523.
    View in: PubMed
    Score: 0.022
  39. Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY). Am J Hematol. 2021 04 01; 96(4):404-417.
    View in: PubMed
    Score: 0.022
  40. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol. 2000 Nov; 111(2):482-90.
    View in: PubMed
    Score: 0.021
  41. Epidemiology and clinical characteristics of viral infections in hospitalized children and adolescents with cancer in Lebanon. PLoS One. 2020; 15(9):e0239258.
    View in: PubMed
    Score: 0.021
  42. Wiskott-Aldrich Syndrome in four male siblings from a consanguineous family from Lebanon. Clin Immunol. 2020 10; 219:108573.
    View in: PubMed
    Score: 0.021
  43. Isolated Central Nervous System Relapse Following Treatment Reduction in Low-risk Acute Lymphoblastic Leukemia at the Children's Cancer Center of Lebanon. J Pediatr Hematol Oncol. 2020 08; 42(6):e428-e433.
    View in: PubMed
    Score: 0.021
  44. Port-a-Cath fracture and migration in paediatric cancer patients: incidence and management at a tertiary care centre - a 15-year experience. Cardiol Young. 2020 Jul; 30(7):986-990.
    View in: PubMed
    Score: 0.021
  45. Paediatric to adult transition care for patients with sickle cell disease: a global perspective. Lancet Haematol. 2020 Apr; 7(4):e329-e341.
    View in: PubMed
    Score: 0.020
  46. The value of diffusion weighted imaging and apparent diffusion coefficient in primary Osteogenic and Ewing sarcomas for the monitoring of response to treatment: Initial experience. Eur J Radiol. 2020 Mar; 124:108855.
    View in: PubMed
    Score: 0.020
  47. Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3). Contemp Clin Trials. 2019 10; 85:105835.
    View in: PubMed
    Score: 0.019
  48. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
    View in: PubMed
    Score: 0.019
  49. Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study. Pharmacogenet Genomics. 2018 08; 28(8):189-195.
    View in: PubMed
    Score: 0.018
  50. Displaced children with cancer in Lebanon: A sustained response to an unprecedented crisis. Cancer. 2018 04 01; 124(7):1464-1472.
    View in: PubMed
    Score: 0.017
  51. Routine surveillance imaging after end of therapy for pediatric extracranial tumors: A retrospective analysis. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.017
  52. Pediatric cancer pathology review from a single institution: Neuropathology expert opinion is essential for accurate diagnosis of pediatric brain tumors. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.017
  53. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management. Pediatr Blood Cancer. 2017 Dec; 64(12).
    View in: PubMed
    Score: 0.017
  54. Trends in hematopoietic stem cell transplant activity in Lebanon. Hematol Oncol Stem Cell Ther. 2017 Dec; 10(4):315-320.
    View in: PubMed
    Score: 0.017
  55. First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group. Bone Marrow Transplant. 2017 Jan; 52(1):120-125.
    View in: PubMed
    Score: 0.016
  56. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon. Pediatr Blood Cancer. 2017 01; 64(1):146-150.
    View in: PubMed
    Score: 0.016
  57. Neurologic complications following bone marrow transplantation for sickle cell disease. Bone Marrow Transplant. 1996 Mar; 17(3):405-7.
    View in: PubMed
    Score: 0.015
  58. Effect of Malnutrition at Diagnosis on Clinical Outcomes of Children With Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2016 Mar; 38(2):107-10.
    View in: PubMed
    Score: 0.015
  59. Serum levels of GM-CSF are elevated in patients with thrombocytopenia. Br J Haematol. 1996 Feb; 92(2):486-8.
    View in: PubMed
    Score: 0.015
  60. Wilms tumor: Successes and challenges in management outside of cooperative clinical trials. Hematol Oncol Stem Cell Ther. 2016 Mar; 9(1):20-5.
    View in: PubMed
    Score: 0.015
  61. Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis. Genome Med. 2015 Dec 18; 7:130.
    View in: PubMed
    Score: 0.015
  62. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events. N Engl J Med. 2016 Feb 18; 374(7):625-35.
    View in: PubMed
    Score: 0.015
  63. Approach to Non-Neutropenic Fever in Pediatric Oncology Patients-A Single Institution Study. Pediatr Blood Cancer. 2015 Dec; 62(12):2167-71.
    View in: PubMed
    Score: 0.015
  64. 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Pediatr Blood Cancer. 2015 Aug; 62(8):1427-36.
    View in: PubMed
    Score: 0.014
  65. Pain in children and adolescents with sickle cell anemia: a prospective study utilizing self-reporting. Am J Pediatr Hematol Oncol. 1994 Aug; 16(3):219-24.
    View in: PubMed
    Score: 0.014
  66. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics. 2014 Aug; 24(8):387-96.
    View in: PubMed
    Score: 0.014
  67. A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2014 Jul; 89(7):709-13.
    View in: PubMed
    Score: 0.013
  68. Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Sci Transl Med. 2014 Mar 12; 6(227):227ra33.
    View in: PubMed
    Score: 0.013
  69. Cytomegalovirus retinitis in children and young adults with acute lymphoblastic leukemia in Lebanon. Leuk Lymphoma. 2014 Aug; 55(8):1918-21.
    View in: PubMed
    Score: 0.013
  70. Bone marrow transplantation for sickle cell disease. The United States experience. Am J Pediatr Hematol Oncol. 1994 Feb; 16(1):22-6.
    View in: PubMed
    Score: 0.013
  71. Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon. Pediatr Blood Cancer. 2014 Aug; 61(8):1472-5.
    View in: PubMed
    Score: 0.013
  72. A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2013 Nov; 88(11):E255-60.
    View in: PubMed
    Score: 0.013
  73. Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution. J Pediatr Hematol Oncol. 2013 Jul; 35(5):356-60.
    View in: PubMed
    Score: 0.013
  74. Rhabdomyosarcoma treatment and outcome at a multidisciplinary pediatric cancer center in Lebanon. Pediatr Hematol Oncol. 2012 May; 29(4):322-34.
    View in: PubMed
    Score: 0.012
  75. Correlation of non-mass-like abnormal MR signal intensity with pathological findings surrounding pediatric osteosarcoma and Ewing's sarcoma. Skeletal Radiol. 2012 Nov; 41(11):1453-61.
    View in: PubMed
    Score: 0.012
  76. A preliminary investigation of Beta-hCG expression in patients with osteosarcoma. J Bone Joint Surg Br. 2012 Mar; 94(3):419-24.
    View in: PubMed
    Score: 0.012
  77. Inherited thrombophilia in childhood arterial stroke: data from Lebanon. Pediatr Neurol. 2011 Sep; 45(3):155-8.
    View in: PubMed
    Score: 0.011
  78. Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models. Pediatr Hematol Oncol. 2011 Nov; 28(8):676-81.
    View in: PubMed
    Score: 0.011
  79. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia. Blood Cells Mol Dis. 2011 Aug 15; 47(2):125-8.
    View in: PubMed
    Score: 0.011
  80. Complementary and alternative medicine use among pediatric patients with leukemia: the case of Lebanon. Integr Cancer Ther. 2011 Mar; 10(1):38-46.
    View in: PubMed
    Score: 0.011
  81. Seven-year experience of using Repiphysis expandable prosthesis in children with bone tumors. Pediatr Blood Cancer. 2010 Sep; 55(3):457-63.
    View in: PubMed
    Score: 0.010
  82. The risk of local recurrence along the core-needle biopsy tract in patients with bone sarcomas. Iowa Orthop J. 2010; 30:80-3.
    View in: PubMed
    Score: 0.010
  83. Modeling pathways for low bone mass in children with malignancies. J Clin Densitom. 2009 Oct-Dec; 12(4):441-9.
    View in: PubMed
    Score: 0.010
  84. Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution. Pediatr Hematol Oncol. 2009 Sep; 26(6):439-47.
    View in: PubMed
    Score: 0.010
  85. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood. 2009 Nov 19; 114(21):4632-8.
    View in: PubMed
    Score: 0.010
  86. Abdominal complications of chemotherapy in pediatric malignancies: imaging findings. Clin Imaging. 2009 Jul-Aug; 33(4):253-60.
    View in: PubMed
    Score: 0.010
  87. Addition of ketamine to propofol for initiation of procedural anesthesia in children reduces propofol consumption and preserves hemodynamic stability. Acta Anaesthesiol Scand. 2008 Apr; 52(4):561-5.
    View in: PubMed
    Score: 0.009
  88. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children. Neuropediatrics. 2008 Feb; 39(1):46-50.
    View in: PubMed
    Score: 0.009
  89. Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol. 2007 Jan; 136(2):343-4.
    View in: PubMed
    Score: 0.008
  90. Assessing procedural pain in children with cancer in Beirut, Lebanon. J Pediatr Oncol Nurs. 2006 Nov-Dec; 23(6):311-20.
    View in: PubMed
    Score: 0.008
  91. Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease. J Pediatr Hematol Oncol. 2006 Mar; 28(3):147-53.
    View in: PubMed
    Score: 0.008
  92. Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin. 2006; 30(2):165-70.
    View in: PubMed
    Score: 0.008
  93. Role of temozolomide in spinal cord low grade astrocytomas: results in two paediatric patients. Acta Neurochir (Wien). 2006 Feb; 148(2):175-9; discussion 180.
    View in: PubMed
    Score: 0.008
  94. Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity. J Pediatr. 1985 Oct; 107(4):537-41.
    View in: PubMed
    Score: 0.007
  95. Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. Hemoglobin. 2004 May; 28(2):85-102.
    View in: PubMed
    Score: 0.007
  96. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94.
    View in: PubMed
    Score: 0.007
  97. Transcranial Doppler ultrasonography and neurocognitive functioning in children with sickle cell disease. Pediatrics. 2003 Aug; 112(2):324-31.
    View in: PubMed
    Score: 0.006
  98. Effective treatment of hypereosinophilic syndrome with imatinib mesylate. Hematol J. 2003; 4(6):410-2.
    View in: PubMed
    Score: 0.006
  99. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr. 2001 Dec; 139(6):785-9.
    View in: PubMed
    Score: 0.006
  100. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol. 2000 Jul-Aug; 22(4):335-9.
    View in: PubMed
    Score: 0.005
  101. Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood. 2000 May 15; 95(10):3057-64.
    View in: PubMed
    Score: 0.005
  102. Use of amphotericin B colloidal dispersion in children. J Pediatr Hematol Oncol. 2000 May-Jun; 22(3):242-6.
    View in: PubMed
    Score: 0.005
  103. Costs, charges, and reimbursements for persons with sickle cell disease. J Pediatr Hematol Oncol. 1999 Sep-Oct; 21(5):389-96.
    View in: PubMed
    Score: 0.005
  104. Postdural puncture headache in paediatric oncology patients. Can J Anaesth. 1998 Aug; 45(8):741-5.
    View in: PubMed
    Score: 0.004
  105. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul 02; 339(1):5-11.
    View in: PubMed
    Score: 0.004
  106. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998 Feb; 19(1):110-29.
    View in: PubMed
    Score: 0.004
  107. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood. 1997 Mar 01; 89(5):1533-42.
    View in: PubMed
    Score: 0.004
  108. Myelodysplasia associated with Turner syndrome. J Pediatr Hematol Oncol. 1996 Aug; 18(3):299-301.
    View in: PubMed
    Score: 0.004
  109. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995 Jul 27; 333(4):206-13.
    View in: PubMed
    Score: 0.004
  110. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995 Jun; 126(6):896-9.
    View in: PubMed
    Score: 0.004
  111. Impact of laparoscopic cholecystectomy on the management of cholelithiasis in children with sickle cell disease. J Pediatr Surg. 1994 Feb; 29(2):209-12; discussion 212-3.
    View in: PubMed
    Score: 0.003
  112. Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion. Radiology. 1993 Apr; 187(1):45-9.
    View in: PubMed
    Score: 0.003
  113. The state of the art in pediatric surgery and pediatric oncology at MUSC Children's Hospital. J S C Med Assoc. 1990 May; 86(5):290-3.
    View in: PubMed
    Score: 0.003
  114. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989 06 15; 320(24):1574-80.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.